Mylan
The Pharma Stocks We’re Buying Now
We’re buying pharma stocks - Mylan and McKesson - for their cash flows, pricing power, and growth, all at valuations too cheap to ignore.
We’re buying pharma stocks - Mylan and McKesson - for their cash flows, pricing power, and growth, all at valuations too cheap to ignore.
View IMA's regulatory filings which includes ADV Part 2A & 2B, form CRS, firm's brochure, our conflicts of interest disclosures,
samples of our quarterly letter, and privacy policy by following this link. © 2026 - All Right Reserved.
